Robust T Cell Responses to Pfizer/BioNTech Vaccine Compared to Infection and Evidence of Attenuated Peripheral CD8+ T Cell Responses Due to COVID-19

Using “spheromer” peptide-MHC multimer reagents, investigators analyzed healthy subjects receiving two doses of the Pfizer/BioNTech BNT162b2 vaccine.
AbstractFull ArticlePress ReleaseGraphical Abstract

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News